article thumbnail

Omnibus Spending Law: Provisions Will Bolster Medicines Supply Chain Insights and Advanced Manufacturing Technologies

Quality Matters

Leveraging insights from data on USP standards distribution and usage at more than 22,000 locations worldwide and 40+ external data sets, USP launched the Medicine Supply Map in 2021 to provide an early-warning capability for supply chain vulnerabilities.

article thumbnail

Accelerating pharma’s sustainability efforts

Express Pharma

Integrating ESG considerations into core pharma operations India, known as the “Pharmacy of the World,” produces over 20 per cent of the global supply of generic medicines and plays a vital role in vaccine production, as per the Investindia.gov.in It meets the healthcare needs of over 1.4

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

USP’s commitment to ESG considerations for a healthier, more sustainable world

Quality Matters

Agency for International Development (USAID) and others, we strengthened 22 national medicines regulatory authorities, supported 23 national control and diagnostic laboratories to meet global standards, and advanced quality production with 36 manufacturers for 50 medical products. These USP documentary standards are recognized in U.S.

article thumbnail

World Standards Day: Recognizing How Standards Enable a Strong Medicines Supply Chain

Quality Matters

With this extensive system in place, patients can trust that medicines with the same name will be consistent in quality no matter who manufactures it or where in the world it is made. Since manufacturers know the precise quality specifications, standards help make the approval process for generic medicines more efficient.

article thumbnail

Pharmaceutical Continuous Manufacturing: Regulatory landscape in the spotlight at USP workshop

Quality Matters

For example, while some stakeholders may perceive PCM to be primarily for innovators and not for makers of generic medicines or biotech companies, it “can be for generic companies, biotechnology companies, and so on, and we have had engagements with generic drug companies in our emerging technologies program already,” Fisher said.

article thumbnail

Manufacturing solutions are essential to strengthen the global medicines supply chain

Quality Matters

government’s fiscal 2023 funding bill , signed into law in December 2022, included a range of specific provisions to support medicines supply chain resilience, including those supporting development of AMT through creation of national centers of excellence. The non-profit maker of essential generic medicines was established by a group of U.S.

article thumbnail

What a mild recession could mean for small biotechs in 2023

Pharmaceutical Technology

To build an advanced pharmaceutical manufacturing cluster in the Richmond-Petersburg area, the Alliance for Building Better Medicine aims to support the early growth of local pharmaceutical manufacturers. The US Department of Commerce’s Economic Development Administration (EDA) awarded the organization $52.9